Association between TGFBR2 Gene Polymorphism (rs2228048, Asn389Asn) and Intracerebral Hemorrhage in Korean Population

REFERENCES

• American Heart Association. (2010). Heart Disease and Stroke Statistics-2005 Update. American Heart Association.
   Google Scholar
• Baas, A.F., Medic, J., van ’t Slot, R., de Kovel, C.G., Zhernakova, A., Geelkerken, R.H., Kranendonk, S.E., van Sterkenburg, S.M., Grobbee, D.E., Boll, A.P., Wijmenga, C., Blankensteijn, J.D., Ruigrok, Y.M. (2010). Association of the TGF-beta receptor genes with abdominal aortic aneurysm. Eur. J. Hum. Genet. 18(2):240–244.
   Google Scholar
• Gil-Núñez, A. (2007). The metabolic syndrome and cerebrovascular disease: suspicion and evidence. Cerebrovasc. Dis. 24 Suppl 1:64–75.
   Google Scholar
• Grysiewicz, R.A., Thomas, K., Pandey, D.K. (2008). Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol. Clin. 26(4):871–895.
   PubMed Web of Science ®Google Scholar
• Gulubova, M., Manolova, I., Ananiev, J., Julianov, A., Yovchev, Y., Peeva, K. (2010). Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer. Int. J. Colorectal Dis. 25(5):591–599.
   Google Scholar
• Ikeda, H. (2005). Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas. Brain Tumor Pathol. 23(1):7–12.
   Google Scholar
• Jin, G., Wang, L., Chen, W., Hu, Z., Zhou, Y., Tan, Y., Wang, J., Hua, Z., Ding, W., Shen, J., Zhang, Z., Wang, X., Xu, Y., Shen, H. (2007). Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. Int. J. Cancer 120(6):1330–1335.
   Google Scholar
• Lanktree, M.B., Dichgans, M., Hegele, R.A. (2010). Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 41(4):825–382.
   PubMed Web of Science ®Google Scholar
• Li, M.O., Sanjabi, S., Flavell, R.A. (2006). Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25(3):455–471.
   PubMed Web of Science ®Google Scholar
• Lin, H.Y., Moustakas, A., Knaus, P., Wells, R.G., Henis, Y.I., Lodish, H.F. (1995). The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands. J. Biol. Chem. 270(6):2747–2754.
   PubMed Web of Science ®Google Scholar
• Lin, Y.C., Chang, Y.M., Yu, J.M., Yen, J.H., Chang, J.G., Hu, C.J. (2005). Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. Atherosclerosis 180(2):305–309.
   Google Scholar
• Loeys, B.L., Chen, J., Neptune, E.R., Judge, D.P., Podowski, M., Holm, T., Meyers, J., Leitch, C.C., Katsanis, N., Sharifi, N., Xu, F.L., Myers, L.A., Spevak, P.J., Cameron, D.E., De Backer, J., Hellemans, J., Chen, Y., Davis, E.C., Webb, C.L., Kress, W., Coucke, P., Rifkin, D.B., De Paepe, A.M., Dietz, H.C. (2005). A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37(3):275–281.
   PubMed Web of Science ®Google Scholar
• Mizuguchi, T., Collod-Beroud, G., Akiyama, T., Abifadel, M., Harada, N., Morisaki, T., Allard, D., Varret, M., Claustres, M., Morisaki, H., Ihara, M., Kinoshita, A., Yoshiura, K., Junien, C., Kajii, T., Jondeau, G., Ohta, T., Kishino, T., Furukawa, Y., Nakamura, Y., Niikawa, N., Boileau, C., Matsumoto, N. (2004). Heterozygous TGFBR2 mutations in Marfan syndrome. Nat. Genet. 36(8):855–860.
   PubMed Web of Science ®Google Scholar
• Muengtaweepongsa, S., Singh, N.N., Cruz-Flores, S. (2010). Pontine warning syndrome: case series and review of literature. J. Stroke Cerebrovasc. Dis. 19(5):353–356.
   Google Scholar
• Parsons, R., Myeroff, L.L., Liu, B., Willson, J.K., Markowitz, S.D., Kinzler, K.W., Vogelstein, B. (1995). Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res. 55(23):5548–5550.
   PubMed Web of Science ®Google Scholar
• Pyzik, M., Piccirillo, C.A. (2006). The TGF-beta1/Foxp3 regulatory axis in immune self-tolerance: implications for health and disease. Inflamm. Allergy Drug Targets 5(3):167–177.
   Google Scholar
• Rechtman, M.M., Nakaryakov, A., Shapira, K.E., Ehrlich, M., Henis, Y.I. (2009). Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors. J. Biol. Chem. 284(12):7843–7852.
   Google Scholar
• Reuter, B., Bugert, P., Stroick, M., Bukow, S., Griebe, M., Hennerici, M.G., Fatar, M. (2009). TIMP-2 gene polymorphism is associated with intracerebral hemorrhage. Cerebrovasc. Dis. 28(6):558–563.
   Google Scholar
• Rezaii, A.A., Hoseinipanah, S.M., Hajilooi, M., Rafiei, A.R., Shikh, N., Haidari, M. (2009). Interleukin-1 receptor antagonist gene polymorphism and susceptibility to ischemic stroke. Immunol. Invest. 38(3-4):220–230.
   PubMed Web of Science ®Google Scholar
• Shi, K.L., He, B., Wang, J.J., Zou, L.P. (2009). Role of TNF-alpha gene variation in idiopathic childhood ischemic stroke: a case-control study. J. Child. Neurol. 24(1):25–29.
   Google Scholar
• Shiber, J.R., Fontane, E., Adewale, A. (2010). Stroke registry: hemorrhagic vs ischemic strokes. Am. J. Emerg. Med. 28(3):331–333.
   PubMed Web of Science ®Google Scholar
• Singh, K.K., Rommel, K., Mishra, A., Karck, M., Haverich, A., Schmidtke, J., Arslan-Kirchner, M. (2006). TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum. Mutat. 27(8):770–777.
   PubMed Web of Science ®Google Scholar
• Tanaka, S., Mori, M., Mafune, K., Ohno, S., Sugimachi, K. (2000). A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma. Br. J. Cancer 82(9):1557–1660.
   Google Scholar
• Tseng, Z.H., Vittinghoff, E., Musone, S.L., Lin, F., Whiteman, D., Pawlikowska, L., Kwok, P.Y., Olgin, J.E., Aouizerat, B.E. (2009). Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm. 6(12):1745–1750.
   Google Scholar
• Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J.V., Lin, A.H., Crews, L., Tremblay, P., Mathews, P., Mucke, L., Masliah, E., Wyss-Coray, T. (2006). Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer’s pathology. J. Clin. Invest. 116(11):3060–3069.
   PubMed Web of Science ®Google Scholar
• Van Asch, C.J., Luitse, M.J., Rinkel, G.J., van der Tweel, I., Algra, A., Klijn, C.J. (2010). Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 9:167–176.
   PubMed Web of Science ®Google Scholar
• Wang, J.J., Jiang, L.Q., He, B., Shi, K.L., Li, J.W., Zou, L.P. (2009). The association of CTLA-4 and CD28 gene polymorphisms with idiopathic ischemic stroke in the paediatric population. Int. J. Immunogenet. 36(2):113–118.
   Google Scholar
• Yoshida, T., Kato, K., Yokoi, K., Oguri, M., Watanabe, S., Metoki, N., Yoshida, H., Satoh, K., Aoyagi, Y., Nishigaki, Y., Nozawa, Y., Yamada, Y. (2009). Association of gene polymorphisms with chronic kidney disease in high- or low-risk subjects defined by conventional risk factors. Int. J. Mol. Med. 23(6):785–792.
   Google Scholar
• Yun, J.Y., Uhm, Y.K., Kim, H.J., Lim, S.H., Chung, J.H., Shin, M.K., Yim, S.V., Lee, M.H. (2010). Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population. Int. J. Immunogenet. 37(4):289–291.
   Google Scholar